Figure 3: Representative typical Symptoms of COVID-19 with tentative percentages. A. Percent of all reported symptoms of Pandemic2019- nCoV affected patients between January 23 and May 25, 2020 outbreak (www.worldometers.info/coronavirus.com). b. The disorders caused by pandemic COVID-19 infection with an approximate 5.2 days incubation period. There are general similarities in the symptoms between COVID-19 and previous life threading betacoronavirus SARS and MERS but COVID-19 showed some unique clinical features like rhinorrhoea, sneezing, and sore throat.
References
  1. Ahamed, M. M., Naznin, R. N., Saha, O., & Rahaman, M. M. Recommendation of fecal specimen for routine molecular detection of SARS-CoV-2 and for COVID-19 discharge criteria. Pathogens and global. Health 2020; 1.
  2. Islam, M. M., Rakhi, N. N., Islam, O. K., Saha, O., & Rahaman, M. M. Challenges to be considered to evaluate the COVID-19 preparedness and outcome in Bangladesh. International Journal of Healthcare Management 2020; 1-2.
  3. Zhang, L., Yang, J. R., Zhang, Z., & Lin, Z. Genomic variations of SARS-CoV-2 suggest multiple outbreak sources of transmission. medRxiv 2020.
  4. Pang, J., Wang, M. X., Ang, I. Y. H., Tan, S. H. X., Lewis, R. F., Chen, J. I. P., … & Ng, X. Y. Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review. J of Clin Med 2020; 9(3): 623.
  5. Chu, D. K., Pan, Y., Cheng, S., Hui, K. P., Krishnan, P., Liu, Y., … & Peiris, M. Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clin chemistry 2020.
  6. Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., … & Yu, T. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet 2020; 395(10223): 507-513.
  7. Park, W. B., Kwon, N. J., Choi, S. J., Kang, C. K., Choe, P. G., Kim, J. Y., … & Seo, J. S. Virus isolation from the first patient with SARS-CoV-2 in Korea. Journal of Korean Medical Science2019; 35(7).
  8. Conway, M. J. Identification of coronavirus sequences in carp cDNA from Wuhan, China. Journal of Medical Virology .2020.
  9. Wu A, Peng Y, Huang B et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe 2020.
  10. Wang, H., Li, X., Li, T., Zhang, S., Wang, L., Wu, X., & Liu, J. The genetic sequence, origin, and diagnosis of SARS-CoV-2. European Journal of Clinical Microbiology & Infectious Diseases 2020; 1.
  11. Zhang, T., Wu, Q., & Zhang, Z. Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak. Current Biology 2020.
  12. Su, Y., Anderson, D., Young, B., Zhu, F., Linster, M., Kalimuddin, S., … & Yan, G. Discovery of a 382-nt deletion during the early evolution of SARS-CoV-2. bioRxiv 2020.
  13. Khailany, R. A., Safdar, M., & Ozaslan, M. Genomic characterization of a novel SARS-CoV-2. Gene reports19 , 100682. Advance online publication. 2020. https://doi.org/10.1016/j.genrep.2020.100682
  14. Forster, P., Forster, L., Renfrew, C., & Forster, M. Phylogenetic network analysis of SARS-CoV-2 genomes. Proceedings of the National Academy of Sciences 2020; 117(17), 9241-9243.
  15. van Dorp, L., Acman, M., Richard, D., Shaw, L. P., Ford, C. E., Ormond, L., … & Ortiz, A. T. Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. Infection, Genetics and Evolution 2020; 104351.
  16. Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., … & Cheng, Z. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 2020; 395(10223): 497-506.
  17. Kumar, M., Taki, K., Gahlot, R., Sharma, A., & Dhangar, K. A chronicle of SARS-CoV-2: Part-I-Epidemiology, diagnosis, prognosis, transmission and treatment. Science of The Total Environment2020; 139278.
  18. Ramzy, A., May. T., 2nd February 2020. Philippines Reports First Coronavirus Death Outside China. Available at https://www.nytimes.com/2020/02/02/world/asia/philippines - coronavirus -china.html
  19. Yang, N., Shen, Y., Shi, C., Ma, A. H. Y., Zhang, X., Jian, X., … & Fu, Y. In-flight Transmission Cluster of COVID-19: A Retrospective Case Series. medRxiv 2020.
  20. Reuters, 2020 b. ”Special Report: Italy and South Korea virus outbreaks reveal disparity in deaths and tactics”. https://www.reuters.com/article/us -health -coronaviru s -response -specialre - idUSKBN20Z27P.
  21. Yee, J., Unger, L., Zadravecz, F., Cariello, P., Seibert, A., Johnson, M. A., & Fuller, M. J. Novel coronavirus 2019 (COVID‐19): Emergence and implications for emergency care. J of the American College of Emergency Physicians Open 2020.
  22. Jing, Q. L., Liu, M. J., Yuan, J., Zhang, Z. B., Zhang, A. R., Dean, N. E., … & Lu, Y. Household Secondary Attack Rate of COVID-19 and Associated Determinants. medRxiv 2020.
  23. Bi Q, Wu Y, Mei S, et al. Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts. medRxiv 2020. doi.org/10.1101/2020.03.03.20028423.
  24. Lau JTF, Lau M, Kim JH, et al. Probable Secondary Infections in Households of SARS Patients in Hong Kong. Emerg Infect Dis 2004;10: 235-243.
  25. Nao, N., Shirato, K., Katano, H., Matsuyama, S., & Takeda, M. Detection of second case of 2019-nCoV infection in Japan (corrected version). Available online: https://www.who.int/docs/defaultsource/coronaviruse/method-niid-20200123-2.pdf?sfvrsn=fbf75320_7 (accessed on 28 January 2020)
  26. Ludvigsson, J. F. Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults. Acta Paediatrica 2020; 109 (6), 1088-1095.
  27. Cai J, Xu J, Lin D, et al. A case series of children with 2019 novel coronavirus infection: clinical and epidemiological features. Clin Infect Dis 2020. https://doi.org/10.1093/cid/ciaa198.
  28. Yan, J., Guo, J., Fan, C., Juan, J., Yu, X., Li, J., … & Lei, D. Coronavirus disease 2019 (COVID-19) in pregnant women: A report based on 116 cases. American journal of obstetrics and gynecology2020.
  29. Yang, Z., Wang, M., Zhu, Z., & Liu, Y. Coronavirus disease 2019 (COVID-19) and pregnancy: a systematic review. The Journal of Maternal-Fetal & Neonatal Medicine 2020; 1-4.
  30. Huang, I., Pranata, R. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis. j intensive care 2020;  8:  36. https://doi.org/10.1186/s40560-020-00453-4.
  31. Ai T, Yang Z, Hou H, et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology 2020;200642. DOI:10.1148/radiol.2020200642
  32. Ye, G., Pan, Z., Pan, Y., Deng, Q., Chen, L., Li, J., & Wang, X. Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation. Journal of Infection 2020.
  33. Cherry, J. D., & Krogstad, P. SARS: The First Pandemic of the 21 st Century. Pediatric research 2020; 56 (1): 1-5.
  34. Shen, M., Zhou, Y., Ye, J., AL-maskri, A. A. A., Kang, Y., Zeng, S., & Cai, S. Recent advances and perspectives of nucleic acid detection for coronavirus. J of Pharmaceutical Analysis 2020.
  35. Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis 2020;
  36. Wölfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature 2020.
  37. Rosa, S., & Santos, W. C. Clinical trials on drug repositioning for COVID-19 treatment. Revista panamericana de salud publica = Pan American journal of public health . 2020; 44: e40. https://doi.org/10.26633/RPSP.2020.40
  38. Wu, R., Wang, L., Kuo, H. C. D., Shannar, A., Peter, R., Chou, P. J., … & Poiani, G. J. An Update on Current Therapeutic Drugs Treating COVID-19. Current Pharmacology Reports 2020; 1.
  39. Cheng, Y., Wong, R., Soo, Y. O. Y., Wong, W. S., Lee, C. K., Ng, M. H. L., … & Cheng, G. (2005). Use of convalescent plasma therapy in SARS patients in Hong Kong. European Jl of Clin Microbiol and Infectious Dis 2005; 24(1): 44-46.
  40. Soo, Y. O. Y., Cheng, Y., Wong, R., Hui, D. S., Lee, C. K., Tsang, K. K. S., … & Sung, J. J. Y. Retrospective comparison of convalescent plasma with continuing high‐dose methylprednisolone treatment in SARS patients. Clin microbiol and infection 2004; 10(7): 676-678.